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Available online 30 July 2016Background: Osteoporotic fractures frequently require inpatient care, and are associated with elevated risks of
morbidity,mortality, and re-hospitalization. A comprehensive evaluation of healthcare costs, resource utilization,
and outcomes associated with osteoporosis (OP)-related fractures treated in US hospitals was undertaken.
Methods: A retrospective analysis using the Premier Perspective Database (2010−2013) was conducted. Study
population comprised patients aged ≥50 years hospitalized with a principal diagnosis of a closed or pathologic
fracture commonly associatedwith OP; theﬁrst qualifying hospitalizationwas designated the “index admission”.
Patientswith evidence ofmajor trauma,malignancy, or other non-OP conditions thatmay lead topathologic frac-
ture during the index admissionwere excluded. Studymeasures included healthcare costs (in 2013 USD), length
of stay (LOS), intensive care unit (ICU) use, andmortality during the index admission, as well as 60-day fracture-
related readmission.
Results: A total of 268,477 patients were admitted to hospital (n= 548 hospitals) with a principal diagnosis of an
OP-related fracture; mean (SD) age was 78 (11) years, 75% were female, 69% had ≥2 comorbidities, and 82% of
patients had a diagnostic code for accidental fall. Among all OP-related fracture admissions, mean (95% CI) hos-
pital cost was $12,839 (12,784–12,893) and LOS was 5.1 (5.1–5.1) days; during the admission, ICU use was 7.4%
(7.3–7.5) and mortality was 1.5% (1.5–1.6), and during the 60-day post-discharge period, fracture-related read-
mission was 2.3% (2.2–2.4).
Conclusions:Hospital costs associatedwith the acute treatment of OP-related fractures are substantial, especially
among patients with fractures of the hip, femur, and spine. Among patients with vertebral fractures—the second
most common reason for admission—mortality and ICU use were notably high, and costs and LOS were higher
than among those with non-vertebral fractures (excluding hip). Interventions that are effective in reducing frac-
ture risk have the potential to yield substantial cost savings.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Mortality1. Introduction
Osteoporosis (OP) is a condition of decreased bone density that af-
fects aging Americans, especially post-menopausal women (U.S.
Department of Health and Human Services, 2004). In older Americans,
OP is the most common cause of bone fracture, often termed “fragility
fractures” (U.S. Department of Health and Human Services, 2004).
These fractures typically result from minimal injury, such as a fall from
standing height or less that is insufﬁcient to fracture a normal bone
(Brown and Josse, 2002).ICU, intensive care unit; DRG,
ory; OR, operating room; CPI,
n.
our Davis Court, Brookline, MA
. This is an open access article underThe clinical and economic burden of fragility fractures has been eval-
uated in a number of retrospective studies characterizing inpatient and/
or ambulatory healthcare utilization, costs, and outcomes (Singer et al.,
2015; Shauver et al., 2011; Christensen et al., 2010; Pike et al., 2010; Shi
et al., 2009; Bass et al., 2008; Kilgore et al., 2009; Sasser et al., 2005; Lad
et al., 2007; Orsini et al., 2005; Russo et al., 2009; King et al., 2009).
While these studies are informative, they differ in design, study sample,
duration of observation, and/or outcomes considered. Moreover, no re-
cent study has reported hospital costs associated with OP-related frac-
tures by the site of the fracture, and no recent study has reported
hospital costs associated with OP-related fractures on an overall basis
and by cost component. Such information is especially critical for the ef-
ﬁcient allocation of scarce healthcare resources, as the musculoskeletal
system is second only to the circulatory system accounting for 14% of
total inpatient expenditures (Pfuntner et al., 2013). To address this
gap in the literature, we undertook a retrospective study using dis-
charge records from over 500 hospitals to quantify levels of resourcethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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OP-related fractures treated in the inpatient setting.2. Methods
2.1. Study design and data source
This study employed a retrospective cross-sectional/cohort design,
and data from the Premier Perspective Database spanning January 1,
2010 to September 30, 2013. The Premier Perspective Database includes
validated discharge ﬁles from all inpatient admissions from N500 geo-
graphically diverse US hospitals. For each inpatient admission, available
data include patient demographics; admission and discharge dates; ad-
mission type and source; diagnoses and procedures; medications; labo-
ratory, diagnostic, and therapeutic services; diagnosis-related group
(DRG); major diagnostic category (MDC); DRG-based severity mea-
sures; discharge disposition; and total (actual) costs associated with
treatment. Selected physician characteristics (e.g., specialty) and hospi-
tal characteristics (e.g., bed size, location, teaching status) are also avail-
able. A detailed description of the data source, and methods employed
to identify the study population and deﬁne study variables, may be
found in Online supplement.2.2. Study population
The study population comprised all patients aged ≥50 years who,
from March 2010 through September 2013, were hospitalized for the
treatment (i.e., discharged with a ﬁrst-listed diagnosis) of selected
closed or pathologic fractures commonly associatedwith OP (“OP-relat-
ed fractures”), including: hip, femur, vertebral, and other non-vertebral
(including humerus, ankle, pelvis, tibia/ﬁbula, distal radius/ulna, proxi-
mate radius/ulna, and clavicle). The ﬁrst such hospitalization during the
period of observation was designated the “index admission”.
Patients with evidence of major trauma,malignancy, or other condi-
tions associated with pathologic fracture—except for OP—and those
transferred to hospital from another acute-care facility were excluded
from the study population. Patients who were hospitalized with a
ﬁrst-listed or second-listed diagnosis code for any type of fractureFig. 1. Distribution of admissions for treatment of o(ICD-9-CM 800-829, 733.1x) within the 60-day period prior to the
index hospitalization also were excluded.
2.3. Study measures
Hospital costs, overall and by component of care (e.g., room/board,
operating room [OR], laboratory, pharmacy, radiology, supplies) were
determined from clinical and billing records, and represent the
hospital's internal assessment of the actual cost to the hospital of deliv-
ering goods and services. Hospital costs were adjusted—as
warranted—to 2013 US dollars based on the hospital component of
the Consumer Price Index (CPI) (Statistics, n.d.). Other study measures
ascertained during the index hospitalization (i.e., from admission to dis-
charge) included the number of days in hospital (i.e., hospital length of
stay [LOS]), inpatientmortality (died vs. alive), intensive care unit (ICU)
use (yes vs. no), and ICU days. Re-hospitalization for any fracture (ﬁrst/
second-listed diagnosis) during the 60-day period following discharge
from the index admission also was evaluated.
2.4. Statistical analyses
Characteristics of patients, their admission, and their hospital for the
index admission were descriptively analyzed. Patient characteristics in-
cluded: age, gender, and race/ethnicity, primary payer, and comorbidity
proﬁle. Admission characteristics included: DRG/MDC, DRG-severity
index, admission source, admission type, and calendar year of admis-
sion. Hospital characteristics included: hospital bed size, hospital loca-
tion, hospital type, and hospital geographic region. Categorical
variables were reported as counts and percentages; for continuous var-
iables, means, standard deviations, and medians were reported.
Hospital costs, hospital LOS, hospital mortality, ICU use, and re-hos-
pitalization were summarized using means, percentages, and corre-
sponding 95% conﬁdence intervals. For binary measures, conﬁdence
intervalswere computedusing theWilson score interval; conﬁdence in-
tervals for continuous measures were computed using a normal distri-
bution. Analyses were conducted using data from all patients who
qualiﬁed for inclusion in the study population, and within subgroups
deﬁned therein on the basis of fracture type (i.e., hip, femur, vertebral,
and other non-vertebral).steoporosis-related fracture, by fracture type.
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3.1. Patient characteristics
The study population included 268,477 patients whowere hospital-
ized for the treatment of selected closed or pathologic OP-related frac-
tures and met all other inclusion/exclusion criteria (Online
supplement, Tables 1–2). One-half of all patients were hospitalized for
hip fracture; other non-vertebral/non-femoral fractures (31%), verte-
bral fractures (14%), and femur fractures (5%) accounted for the remain-
der (Fig. 1). Among patients admitted for other non-vertebral fractures,
principal sites were humerus (9%), ankle (8%), and pelvis (7%).
Mean (SD) age of the study population was 78 (±11) years, and
ranged from 73 (±12) years (other non-vertebral/non-femoral) to 80Table 1
Characteristics of patients admitted to hospital for treatment of osteoporosis-related fracture.
Type of fracture
All (N = 268,477) Hip (N = 133,424)
Patient characteristics
Age (years)
Mean (SD) 77.5 (10.9) 79.9 (9.4)
Median 81 83
Gender, %
Female 75.4 72.9
Male 24.6 27.1
Race/ethnicity, %
White 78.9 79.9
Black 4.3 3.9
Hispanic 1.1 1.0
Other 15.6 15.2
Primary payer, %
Medicare 82.3 87.6
Medicaid 2.7 2.1
Other government provider 0.5 0.4
Managed care 7.7 4.9
Non-managed care commercial 2.9 2.2
Other payer 3.9 2.7
Commercial 10.6 7.1
Other 4.3 3.1
Evidence of fall, % 82.4 87.8
Comorbidities, %b
Cardiovascular disease 45.7 50.4
Osteoporosis/Osteopenia 27.1 25.2
Diabetes 24.7 23.2
Osteoarthritis 21.6 21.8
Hypothyroidism 21.0 21.2
Lung disease 19.8 22.2
Mobility impairments 19.6 19.9
Renal disease 15.7 17.8
Depression 15.6 15.1
Dementia and related conditions 14.0 18.2
Vision impairments 8.0 8.9
Rheumatoid arthritis 3.0 2.6
Parkinson's disease 2.4 3.0
Liver disease 2.4 2.1
Muscle atrophy/muscle weakness/sarcopenia 0.4 0.4
Number of comorbidities, %
0 10.9 8.1
1 19.8 18.6
2 23.6 24.2
≥3 45.8 49.1
Admission characteristics
Admission source, %
Emergency room 13.7 14.2
Non-health care facility 74.3 73.7
Clinic 4.4 3.4
Transfer from another non-acute facility 3.3 4.3
Other/unknown 4.3 4.5
SD: standard deviation.
a Non-vertebral excluding hip and femur fractures.
b Comorbidities for which prevalence b 10%: vision impairments, rheumatoid arthritis, Park(±9) years (hip) (Table 1). Cardiovascular disease was the most com-
mon comorbidity (46%), followed by osteoporosis/osteopenia (27%);
conditions associated with pain or physical impairment also were
prominent (osteoarthritis, 22%; mobility impairments, 20%), as was ev-
idence of fall (82%). Almost 75% of all patients were admitted from a
non-healthcare facility; 14% were admitted via the emergency
department.
3.2. Costs and outcomes
On an overall basis (i.e., for all OP-related fractures), mean total hos-
pital costs were $12,839, and mean hospital LOS was 5.1 days (Fig. 2);
mean LOS was 5.6 days for men, and was 4.9 days for women. Hospital
costs and LOS were highest for femoral fractures ($16,423 and 5.8 days,Femur (N = 12,811) Other non-vertebrala (N = 83,759) Vertebral (N = 38,483)
75.8 (11.1) 73.4(12.0) 78.8 (10.0)
78 75 82
82.8 79.4 72.7
17.2 20.6 27.3
75.4 77.9 79.0
7.5 5.1 3.1
1.3 1.2 1.2
15.8 15.8 16.7
81.5 72.2 86.3
3.1 3.6 2.6
0.5 0.0 0.4
8.0 0.0 5.7
3.0 0.0 2.3
3.8 0.0 2.7
11.1 17.4 8.0
4.3 6.9 3.1
82.9 86.3 55.2
44.4 37.2 48.1
32.2 21.4 44.5
30.2 27.0 23.5
29.0 19.8 22.6
22.3 20.2 21.5
17.6 15.2 22.1
23.1 19.0 18.9
16.7 13.0 13.6
15.3 16.1 16.2
11.6 8.7 11.6
7.7 6.5 8.0
4.6 2.8 4.2
1.6 1.7 2.6
2.3 2.6 3.1
0.3 0.3 0.5
8.7 17.1 7.5
18.2 22.7 17.9
23.6 22.5 23.9
49.4 37.7 50.6
14.4 12.9 13.7
73.5 75.3 74.5
3.9 5.7 5.4
3.9 2.1 2.4
4.3 4.0 4.0
inson's disease, liver disease, and muscle atrophy/muscle weakness/sarcopenia.
Fig. 2. Economic costs and clinical outcomes among patients admitted to hospital for treatment of osteoporosis-related fracture.
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4.0 days, respectively). Among the subgroup of other non-vertebral
fractures, mean costs ranged from $6387 for pelvis fracture to $11,760
for humerus fracture (Online supplement, Table 3).
Room and board accounted for approximately one-third of total hos-
pital costs, while supply costs (23%) and OR costs (18%) accounted for
over 40% of total costs; pharmacy costs accounted for 6% of total costs,
and comprised—in large part—hospital solutions (e.g., IV/parenteral so-
dium chloride) (13%), hemostatic modiﬁers (12%), anti-infectives
(12%), and analgesics (11%) (Fig. 3). Most patients (82%) underwent
surgery; this percentage was highest for hip fracture (96%) and lowest
for vertebral fracture (54%).More than one-half (54%) of all fracture patients were discharged
to a skilled/long-term care facility, 27% were discharged to home,
and 14% were discharged to a rehabilitation facility; 2% died in
hospital. Discharge to a skilled/long-term care facility was highest
for pelvic fracture (65%), hip fracture (62%), and femur fracture
(60%), and was notably high (53%) among fracture patients
who were admitted to hospital from non-healthcare facilities
(who account for 74% of all fracture patients), especially among hip
fracture patients (61%) and femoral fracture patients (60%). Read-
mission within 60 days with evidence of fracture was 2.3% on an
overall basis, and was highest for vertebral fracture (5.7%); 7% of all
fracture patients were admitted to the ICU.
Fig. 3. Distribution of total hospital costs for treatment of osteoporosis-related fracture, by component of care.*
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Using the discharge records on over 250,000 patients from over 500
hospitals, we quantiﬁed levels of resource utilization, healthcare costs,
and outcomes associated with OP-related fractures treated in the inpa-
tient setting. Study results suggest that fractures treated in hospital are
costly, averaging—across all fracture types—nearly $13,000 per patient,
the large majority of which was attributable to room and board, sup-
plies, and the OR. Hip fractures (50%) were, by far, the most common
reason for hospital admission, and most of these patients (96%) had
OR-related expenses. Femoral fractures (5%), while less frequent than
hip fractures, had the highest mean total cost ($16,423), OR-related
costs ($3091), and supply costs ($4406)—and the longest hospital stay
(5.8 days). Among patients with vertebral fractures—the second most
common reason for admission (14%)—mortality and ICU usewere nota-
bly high, and costs and LOS were higher than among those with non-
vertebral fractures (excluding hip).
The importance of these fractures extends well beyond the immedi-
ate short-term economic consequences. Hospitalization, immobility, re-
ceipt of anesthesia, and ﬂuid replacement can exacerbate underlying
conditions (e.g., cardiovascular disease) or cause new ones such as uri-
nary or thrombotic complications in patientswithhip fractures, and90%
of the study population had at least one comorbidity (46% had ≥3)
(Carpintero et al., 2014). Fractures also can compound the overall pain
and functional burden of patients, especially those with metabolic and
other musculoskeletal conditions, and hip fractures—in
particular—often lead to loss ofmuscle mass/strength during the opera-
tive and healing process and extended physical therapy (Visser et al.,
2000). Associated functional impairment is a major reason for admis-
sion to skilled nursing facilities (Luppa et al., 2010). Along these lines,
it is notable that in our study, while nearly 75% of all fracture patients
were admitted from non-healthcare facilities, 53% were discharged to
a skilled/long-term care facility and 14%were discharged to a rehabilita-
tion facility.
While this study is the only recent evaluation to report hospital costs
and outcomes associated with OP-related fractures treated in hospital
by site of fracture and cost component, we note that our results are gen-
erally consistent with those from other published studies, notwith-
standing differences in study design, study sample, duration of
observation, and/or outcomes considered (Singer et al., 2015; Shauver
et al., 2011; Christensen et al., 2010; Pike et al., 2010; Shi et al., 2009;Bass et al., 2008; Kilgore et al., 2009; Sasser et al., 2005; Lad et al.,
2007; Orsini et al., 2005; Russo et al., 2009; King et al., 2009). In the
study by Singer and colleagues (Singer et al., 2015), for example,
mean hospital LOS (in 2008–2011) and mean hospital cost (2011US$)
for hip fracture were reported to be ~6 days (vs. 5.6 days in our study)
and ~$15,000 (vs. $14,744 in our study), respectively; comparable esti-
mates also were reported for vertebral fracture (LOS: ~5.5 vs. 5.4; cost:
~$12,500 vs. $11,681), femoral fracture (LOS: ~6 vs. 5.8; cost: ~$17,500
vs. $16,423), as well as other fractures. In the study by Russo et al.
(Russo et al., 2009), mean hospital LOS and mean hospital cost for hip
fracture in 2006 were reported to be 5.7 days and $12,100, while in
the study by King and colleagues (King et al., 2009), estimates of
mean hospital LOS were similar (hip, 6 days; vertebral, ~5 days; wrist,
~3 days; and pelvic, ~5 days). A summary of methods employed in
prior research is provided in Table 4 of Online supplement.
A few limitations of this study are noteworthy. Because there is no
speciﬁc diagnosis code for OP-related fractures, attention was limited
to fractures that are more likely to be caused by OP based on whether
the fracture was closed (vs. open) or pathologic in nature, whether
the fracture was non-traumatic (vs. traumatic), whether the patient
had no evidence of non-osteoporotic conditions associatedwith a path-
ologic fracture (e.g., malignancy), and age (≥50 years)—consistent with
methods employed in other published studies. It is undoubtedly the
case, however, that some OP-related fractures were missed while
some non-OP-related fractures were erroneously included in analyses.
A formal assessment of the accuracy of the algorithm for identifying
OP-related fracture is beyond the scope of this study.
While the study database includes the principal diagnosis for each
admission—which is identiﬁed at discharge as the principal reason the
patient was admitted to hospital—it is possible that some patients
who fractured while in hospital, and those who were admitted with
fracture but for another reason, may have been (e.g., in error or for rea-
sons of reimbursement) assigned a principal diagnosis of OP-related
fracture and thus were erroneously included in the study population.
Because the study database is left-truncated (i.e., hospitalizations before
January 2010 are unobservable), and includes admissions only to Pre-
miermember hospitals, it is unknownwhether theﬁrst observed hospi-
talization (i.e., the “index” admission) during the period of observation
(i.e., March 2010 thru September 2013) for some patients occurred for
the treatment of a new fracture, fracture of the same site as a previous
one, or fracture of a different site. Moreover, because the study database
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the percentage of patients re-admitted for fracture-related reasons fol-
lowing the index admission may be underestimated somewhat.
It is not possible to separate hospital costs attributable to the treat-
ment of OP-related fracture versus other diseases/conditions that
might be present at the time of hospitalization (or that develop while
in hospital). Accordingly, fracture-related costs will undoubtedly in-
clude resources related to the treatment of other conditions and thus
the total burden of fracturesmay be somewhat overestimated. Hospital-
ization costs represent the hospital's internal assessment of the actual
cost to the hospital of delivering goods and services, and thus do not
represent charged or reimbursed amounts. Because these internal as-
sessments may not be completely standardized among member hospi-
tals and are not reﬂective of cost structures in non-member hospitals,
caution should be exercise in generalizing estimates of economic costs
beyond Premier member hospitals.
Finally, the Premier Perspective Database contains data from about
one in every ﬁve hospital discharges in the US, and has been found to
be comparable with NHDS hospitals (a stratiﬁed random sample of all
US acute-care, non-Federal hospitals) in terms of patient age, gender,
length of stay, mortality, primary discharge diagnosis, and primary pro-
cedure groups. While some differences have been noted with respect to
the characteristics of Premier member hospitals (vs. American Hospital
Association [AHA]member hospitals), we believe patients (admissions)
and clinical outcomes should be—roughly speaking—comparable to
those in other US facilities.
5. Conclusion
The clinical and economic burden of fragility fractures is high when
in-hospital treatment is required, especially among patients with frac-
tures of the hip and femur. Even after hospital discharge, however, the
downstream consequences may be substantial as a high proportion of
patients require care in skilled nursing facilities or rehabilitation facili-
ties. Accordingly, interventions that are effective in reducing fracture
risk have the potential to yield substantial cost savings.
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